Query 033423
Match_columns 119
No_of_seqs 56 out of 58
Neff 2.7
Searched_HMMs 46136
Date Fri Mar 29 13:43:06 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/033423.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/033423hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 cd01327 KAZAL_PSTI Kazal-type 99.0 2.9E-10 6.3E-15 70.4 2.5 38 44-84 3-45 (45)
2 smart00280 KAZAL Kazal type se 98.9 3.3E-10 7.1E-15 68.6 1.6 39 46-84 2-46 (46)
3 PF00050 Kazal_1: Kazal-type s 98.9 3.4E-10 7.4E-15 70.3 1.1 34 46-84 8-48 (48)
4 cd00104 KAZAL_FS Kazal type se 98.7 7.2E-09 1.6E-13 60.8 2.0 35 46-84 1-41 (41)
5 PF07648 Kazal_2: Kazal-type s 98.6 1.4E-08 3.1E-13 59.0 0.4 32 52-84 4-42 (42)
6 cd01328 FSL_SPARC Follistatin- 97.8 1.3E-05 2.8E-10 56.5 1.9 33 54-86 37-85 (86)
7 cd01330 KAZAL_SLC21 The kazal- 97.5 4.8E-05 1E-09 49.4 1.7 28 46-76 11-38 (54)
8 TIGR00805 oat sodium-independe 96.9 0.0021 4.5E-08 56.2 5.8 30 45-75 448-481 (633)
9 KOG4578 Uncharacterized conser 96.0 0.0032 6.9E-08 55.2 1.7 66 14-85 8-78 (421)
10 KOG3626 Organic anion transpor 95.9 0.017 3.8E-07 53.5 6.0 43 46-88 514-582 (735)
11 KOG3555 Ca2+-binding proteogly 85.9 0.35 7.6E-06 43.0 1.1 43 43-87 139-186 (434)
12 COG5058 LAG1 Protein transport 81.5 1.1 2.4E-05 39.6 2.3 15 96-110 345-359 (395)
13 PF12178 INCENP_N: Chromosome 40.2 12 0.00027 23.4 0.5 8 101-108 24-31 (38)
14 COG3350 Uncharacterized conser 37.1 18 0.00039 24.1 0.9 7 53-59 4-10 (53)
15 PRK14762 membrane protein; Pro 33.9 42 0.00092 19.8 2.1 15 105-119 9-23 (27)
16 PHA02325 hypothetical protein 29.7 27 0.00059 24.6 0.9 14 55-68 7-23 (72)
17 PF11027 DUF2615: Protein of u 28.5 88 0.0019 23.0 3.5 24 93-116 49-72 (103)
18 KOG4075 Cytochrome c oxidase, 25.1 48 0.001 26.5 1.7 18 102-119 102-119 (167)
19 KOG1607 Protein transporter of 23.4 65 0.0014 27.8 2.3 14 97-110 268-281 (318)
No 1
>cd01327 KAZAL_PSTI Kazal-type pancreatic secretory trypsin inhibitors (PSTI) and related proteins, including the second domain of the ovomucoid turkey inhibitor and the C-terminal domain of the esophagus cancer-related gene-2 protein (ECRG-2), are members of the superfamily of kazal-type proteinase inhibitors and follistatin-like proteins.
Probab=98.98 E-value=2.9e-10 Score=70.41 Aligned_cols=38 Identities=39% Similarity=0.703 Sum_probs=30.4
Q ss_pred CCCccccccCCccccCCCceeccCCCc--c---ccccceeeeeecC
Q 033423 44 ELCPINCFRPDPVCGVDGVTYWCGCPN--A---LCAGVKVAKLGFC 84 (119)
Q Consensus 44 ~~Cpv~Cf~~dpVCGtDGvTY~~gC~~--A---~CaGV~Va~~G~C 84 (119)
+.||. .++||||+||+||.|.|.- + .-..+++.|+|+|
T Consensus 3 ~~Cp~---~~~PVCGsDg~TY~N~C~l~~~~c~~~~~i~~~~~G~C 45 (45)
T cd01327 3 FGCPK---DYDPVCGTDGVTYSNECLLCAENLKRQTNIRIKHDGEC 45 (45)
T ss_pred CCCCC---CCCceeCCCCCEeCCHhHHHHHHhccCCCeEEeecCCC
Confidence 56888 6999999999999999932 1 2345888999988
No 2
>smart00280 KAZAL Kazal type serine protease inhibitors. Kazal type serine protease inhibitors and follistatin-like domains.
Probab=98.94 E-value=3.3e-10 Score=68.64 Aligned_cols=39 Identities=49% Similarity=0.950 Sum_probs=30.0
Q ss_pred Cccccc-cCCccccCCCceeccCCCc--ccc---ccceeeeeecC
Q 033423 46 CPINCF-RPDPVCGVDGVTYWCGCPN--ALC---AGVKVAKLGFC 84 (119)
Q Consensus 46 Cpv~Cf-~~dpVCGtDGvTY~~gC~~--A~C---aGV~Va~~G~C 84 (119)
||..|- .++||||+||+||.|.|.- ++| ..+++.|+|+|
T Consensus 2 C~~~C~~~~~pVCgsdg~TY~N~C~l~~~~c~~~~~i~~~~~G~C 46 (46)
T smart00280 2 CPEACPREYDPVCGSDGVTYSNECHLCKAACESGKSIEVKHDGPC 46 (46)
T ss_pred CCCCCCCCCCccCCCCCCEeCCHhHHHHHHhcCCCCeEEeecCCC
Confidence 333333 5899999999999999932 556 46788999987
No 3
>PF00050 Kazal_1: Kazal-type serine protease inhibitor domain; InterPro: IPR002350 Peptide proteinase inhibitors can be found as single domain proteins or as single or multiple domains within proteins; these are referred to as either simple or compound inhibitors, respectively. In many cases they are synthesised as part of a larger precursor protein, either as a prepropeptide or as an N-terminal domain associated with an inactive peptidase or zymogen. This domain prevents access of the substrate to the active site. Removal of the N-terminal inhibitor domain either by interaction with a second peptidase or by autocatalytic cleavage activates the zymogen. Other inhibitors interact direct with proteinases using a simple noncovalent lock and key mechanism; while yet others use a conformational change-based trapping mechanism that depends on their structural and thermodynamic properties. This family of Kazal inhibitors, belongs to MEROPS inhibitor family I1, clan IA. They inhibit serine peptidases of the S1 family (IPR001254 from INTERPRO) []. The members are primarily metazoan, but includes exceptions in the alveolata (apicomplexa), stramenopiles, higher plants and bacteria. Kazal inhibitors, which inhibit a number of serine proteases (such as trypsin and elastase), belong to family of proteins that includes pancreatic secretory trypsin inhibitor; avian ovomucoid; acrosin inhibitor; and elastase inhibitor. These proteins contain between 1 and 7 Kazal-type inhibitor repeats [, ]. The structure of the Kazal repeat includes a large quantity of extended chain, 2 short alpha-helices and a 3-stranded anti-parallel beta sheet [].The inhibitor makes 11 contacts with its enzyme substrate: unusually, 8 of these important residues are hypervariable []. Altering the enzyme-contact residues, and especially that of the active site bond, affects the the strength of inhibition and specificity of the inhibitor for particular serine proteases [, ]. The presence of this Pfam domain is usually indicative of serine protease inhibitors, however, Kazal-like domains are also seen in the extracellular part of agrins which are not known to be proteinase inhibitors.; GO: 0005515 protein binding; PDB: 1HPT_A 1CGI_I 1CGJ_I 2P6A_D 3HH2_C 2B0U_D 2BUS_A 1BUS_A 1OVO_A 3OVO_A ....
Probab=98.91 E-value=3.4e-10 Score=70.34 Aligned_cols=34 Identities=53% Similarity=1.122 Sum_probs=26.4
Q ss_pred CccccccCCccccCCCceeccCCCcccc-------ccceeeeeecC
Q 033423 46 CPINCFRPDPVCGVDGVTYWCGCPNALC-------AGVKVAKLGFC 84 (119)
Q Consensus 46 Cpv~Cf~~dpVCGtDGvTY~~gC~~A~C-------aGV~Va~~G~C 84 (119)
||. .++||||+||+||.|.|. .| ..++++|.|+|
T Consensus 8 C~~---~~~PVCGsdg~TY~N~C~--lC~~~~~~~~~i~~~~~G~C 48 (48)
T PF00050_consen 8 CPR---EYDPVCGSDGVTYSNECE--LCAANRRSGKNIRIAHDGPC 48 (48)
T ss_dssp EES---SCS-EEETTSEEESSHHH--HHHHHHHTTTSS-EEEESS-
T ss_pred CCC---CCCceECCCCCCccccch--hhhhhcccCCCeEEeecCCC
Confidence 885 699999999999999994 36 45788999988
No 4
>cd00104 KAZAL_FS Kazal type serine protease inhibitors and follistatin-like domains. Kazal inhibitors inhibit serine proteases, such as, trypsin, chyomotrypsin, avian ovomucoids, and elastases. The inhibitory domain has one reactive site peptide bond, which serves the cognate enzyme as substrate. The reactive site peptide bond is a combining loop which has an identical conformation in all Kazal inhibitors and in all enzyme/inhibitor complexes. These Kazal domains (small hydrophobic core of alpha/beta structure with 3 to 4 disulfide bonds) often occur in tandem arrays. Similar domains are also present in follistatin (FS) and follistatin-like family members, which play an important role in tissue specific regulation. The FS domain consists of an N-terminal beta hairpin (FOLN/EGF-like domain) and a Kazal-like domain and has five disulfide bonds. Although the Kazal-like FS substructure is similar to Kazal proteinase inhibitors, no FS domain has yet been shown to be a proteinase inhibitor.
Probab=98.71 E-value=7.2e-09 Score=60.80 Aligned_cols=35 Identities=51% Similarity=0.984 Sum_probs=28.2
Q ss_pred CccccccCCccccCCCceeccCCCccccc------cceeeeeecC
Q 033423 46 CPINCFRPDPVCGVDGVTYWCGCPNALCA------GVKVAKLGFC 84 (119)
Q Consensus 46 Cpv~Cf~~dpVCGtDGvTY~~gC~~A~Ca------GV~Va~~G~C 84 (119)
||. .++||||.||+||.|.| .+.|+ ++.+.|+|.|
T Consensus 1 C~~---~~~pVCgsdg~tY~n~C-~~~~~~c~~~~~~~~~~~g~C 41 (41)
T cd00104 1 CPK---EYDPVCGSDGKTYSNEC-HLGCAACRSGRSITVAHNGPC 41 (41)
T ss_pred CCC---CCCccCCCCCCEECCHh-hhhHHhhcCCCCeEEEeccCC
Confidence 566 47999999999999999 45554 5778888887
No 5
>PF07648 Kazal_2: Kazal-type serine protease inhibitor domain; InterPro: IPR011497 This domain is usually indicative of serine protease inhibitors that belong to Merops inhibitor families: I1, I2, I17 and I31. However, kazal-like domains are also seen in the extracellular part of agrins, which are not known to be protease inhibitors. Kazal domains often occur in tandem arrays and have a central alpha-helix, a short two-stranded antiparallel beta-sheet and several disulphide bonds [, , ]. The amino terminal segment of this domain binds to the active site of its target proteases, thus inhibiting their function.; PDB: 2KMP_A 1LDT_L 2KMR_A 2KMO_A 2KMQ_A 1AN1_I 4E0S_B 3T5O_A 4A5W_B 1LR7_A ....
Probab=98.56 E-value=1.4e-08 Score=58.96 Aligned_cols=32 Identities=38% Similarity=0.834 Sum_probs=26.5
Q ss_pred cCC-ccccCCCceeccCCCcccc------ccceeeeeecC
Q 033423 52 RPD-PVCGVDGVTYWCGCPNALC------AGVKVAKLGFC 84 (119)
Q Consensus 52 ~~d-pVCGtDGvTY~~gC~~A~C------aGV~Va~~G~C 84 (119)
.++ ||||.||+||.|.| ...+ ..+++.++|.|
T Consensus 4 ~~~~PVCg~dg~ty~n~C-~l~~~~c~~~~~~~~~~~g~C 42 (42)
T PF07648_consen 4 EYSSPVCGSDGKTYSNEC-ELRCANCRTNSKIQIVHDGSC 42 (42)
T ss_dssp SSSSTEEETTSEEESSHH-HHHHHHHHHTTTCEEEEESSS
T ss_pred CCCCCEEcCCCCEEhhHH-HHHHHHHhcCCCeEEEeCCCC
Confidence 355 99999999999999 4555 36889999988
No 6
>cd01328 FSL_SPARC Follistatin-like SPARC (secreted protein, acidic, and rich in cysteines) domain; SPARC/BM-40/osteonectin is a multifunctional glycoprotein which modulates cellular interaction with the extracellular matrix by its binding to structural matrix proteins such as collagen and vitronectin. The protein it composed of an N-terminal acidic region, a follistatin (FS) domain and an EF-hand calcium binding domain. The FS domain consists of an N-terminal beta hairpin (FOLN/EGF-like domain) and a small hydrophobic core of alpha/beta structure (Kazal domain) and has five disulfide bonds and a conserved N-glycosylation site. The FSL_SPARC domain is a member of the superfamily of kazal-like proteinase inhibitors and follistatin-like proteins.
Probab=97.77 E-value=1.3e-05 Score=56.54 Aligned_cols=33 Identities=24% Similarity=0.510 Sum_probs=26.9
Q ss_pred CccccCCCceeccCCC--ccccc--------------cceeeeeecCCC
Q 033423 54 DPVCGVDGVTYWCGCP--NALCA--------------GVKVAKLGFCEV 86 (119)
Q Consensus 54 dpVCGtDGvTY~~gC~--~A~Ca--------------GV~Va~~G~Cev 86 (119)
.+|||+||+||.|.|. +++|. -+.|.+.|+|..
T Consensus 37 ~~VCGsDg~TY~s~C~L~r~~C~~~~~~~~~~~~~~~~l~i~Y~G~Ck~ 85 (86)
T cd01328 37 RKVCTNDNETFDSDCELYRTRCLCKGGKKGCRGPKYQHLHLDYYGECKE 85 (86)
T ss_pred CceeCCCCCCcccHhHHhhhHhccCCCCcCCCCCccCeEEEEeeccccC
Confidence 5699999999999993 36664 688899999863
No 7
>cd01330 KAZAL_SLC21 The kazal-type serine protease inhibitor domain has been detected in an extracellular loop region of solute carrier 21 (SLC21) family members (organic anion transporters) , which may regulate the specificity of anion uptake. The KAZAL_SLC21 domain is a member of the superfamily of kazal-like proteinase inhibitors and follistatin-like proteins.
Probab=97.52 E-value=4.8e-05 Score=49.45 Aligned_cols=28 Identities=39% Similarity=0.959 Sum_probs=23.4
Q ss_pred CccccccCCccccCCCceeccCCCccccccc
Q 033423 46 CPINCFRPDPVCGVDGVTYWCGCPNALCAGV 76 (119)
Q Consensus 46 Cpv~Cf~~dpVCGtDGvTY~~gC~~A~CaGV 76 (119)
||.. .++||||.||+||.+.| .|.|...
T Consensus 11 C~~~--~~~PVCg~~g~tY~SpC-~AGC~~~ 38 (54)
T cd01330 11 CSES--AYSPVCGENGITYFSPC-HAGCTNS 38 (54)
T ss_pred CCCC--CcCCccCCCCCEEcCHh-HcCCccc
Confidence 5543 58999999999999999 6999764
No 8
>TIGR00805 oat sodium-independent organic anion transporter. Proteins of the OAT family catalyze the Na+-independent facilitated transport of organic anions such as bromosulfobromophthalein and prostaglandins as well as conjugated and unconjugated bile acids (taurocholate and cholate, respectively). These transporters have been characterized in mammals, but homologues are present in C. elegans and A. thaliana. Some of the mammalian proteins exhibit a high degree of tissue specificity. For example, the rat OAT is found at high levels in liver and kidney and at lower levels in other tissues. These proteins possess 10-12 putative a-helical transmembrane spanners. They may catalyze electrogenic anion uniport or anion exchange.
Probab=96.89 E-value=0.0021 Score=56.23 Aligned_cols=30 Identities=40% Similarity=0.823 Sum_probs=23.8
Q ss_pred CCccccc----cCCccccCCCceeccCCCcccccc
Q 033423 45 LCPINCF----RPDPVCGVDGVTYWCGCPNALCAG 75 (119)
Q Consensus 45 ~Cpv~Cf----~~dpVCGtDGvTY~~gC~~A~CaG 75 (119)
.|..+|. .|+||||.||+||-..| -|.|..
T Consensus 448 ~Cn~~C~C~~~~~~PVCg~~~~tY~SpC-~AGC~~ 481 (633)
T TIGR00805 448 DCNRQCSCDSSFFDPVCGDNGLAYLSPC-HAGCSM 481 (633)
T ss_pred ccCCCCCCCCCCcccccCCCCCEEECcc-ccCCCC
Confidence 4555554 58999999999999999 588853
No 9
>KOG4578 consensus Uncharacterized conserved protein, contains KAZAL and TY domains [General function prediction only]
Probab=96.03 E-value=0.0032 Score=55.24 Aligned_cols=66 Identities=29% Similarity=0.470 Sum_probs=41.7
Q ss_pred HHHHHHHHhhhccccccccccCCCCCCCCCCCCccccc-cCCccccCCCceeccCC--Cccccccc--eeeeeecCC
Q 033423 14 LIFFLALNIGLQLVQSTQESDGVCARFTKPELCPINCF-RPDPVCGVDGVTYWCGC--PNALCAGV--KVAKLGFCE 85 (119)
Q Consensus 14 ~La~~aLl~~d~~~~~~~~s~~~C~~~~e~~~Cpv~Cf-~~dpVCGtDGvTY~~gC--~~A~CaGV--~Va~~G~Ce 85 (119)
+++.++-+++-+-....|-+-+.|. .|.-.|. ...||||+||.||-..| .+|+|-+- .++|.|.|+
T Consensus 8 lv~~L~p~~a~~~s~~~fl~~d~d~------~c~l~C~~~~kPvCasDGrty~srCe~qRAkC~dpql~~~yrG~Ck 78 (421)
T KOG4578|consen 8 LVTWLAPFIATGKSDDQFLKLDADA------ACQLECDDNEKPVCASDGRTYPSRCELQRAKCGDPQLSLKYRGSCK 78 (421)
T ss_pred HHHhhccccccCcCCceeeecccch------hhccccCCCCCCccccCCccchhHHHHHHhhcCCCceeEEecCcHH
Confidence 3335555555443333333333332 2444444 36999999999999888 34899874 569999997
No 10
>KOG3626 consensus Organic anion transporter [Secondary metabolites biosynthesis, transport and catabolism]
Probab=95.92 E-value=0.017 Score=53.50 Aligned_cols=43 Identities=37% Similarity=0.931 Sum_probs=30.7
Q ss_pred Cccccc----cCCccccCCCceeccCC----Cc-------------cccc-----cceeeeeecCCCCC
Q 033423 46 CPINCF----RPDPVCGVDGVTYWCGC----PN-------------ALCA-----GVKVAKLGFCEVGS 88 (119)
Q Consensus 46 Cpv~Cf----~~dpVCGtDGvTY~~gC----~~-------------A~Ca-----GV~Va~~G~Cevg~ 88 (119)
|-.+|. ++.||||.||.||-..| .+ =.|. +..++++|+|+...
T Consensus 514 Cn~~C~C~~~~~~PVCg~~G~tY~SpChAGC~~~~~~~~~~~~ytnCsCv~~~~~~~~~a~~G~C~~~c 582 (735)
T KOG3626|consen 514 CNSDCSCDTSEYEPVCGENGITYFSPCHAGCTESSGTSDGNTIYTNCSCVPTNKNGNGSAKKGYCPNDC 582 (735)
T ss_pred hhcCCCCCCcCcCcccCCCCCEEeChhhhCCcccccCCCCceeeccccccccccCCCceeecCCCCCCc
Confidence 554443 68999999999997655 21 1233 46788999999875
No 11
>KOG3555 consensus Ca2+-binding proteoglycan Testican [General function prediction only]
Probab=85.92 E-value=0.35 Score=42.95 Aligned_cols=43 Identities=35% Similarity=0.678 Sum_probs=31.0
Q ss_pred CCCCccccccCCccccCCCceeccCCCc--cccc---cceeeeeecCCCC
Q 033423 43 PELCPINCFRPDPVCGVDGVTYWCGCPN--ALCA---GVKVAKLGFCEVG 87 (119)
Q Consensus 43 ~~~Cpv~Cf~~dpVCGtDGvTY~~gC~~--A~Ca---GV~Va~~G~Cevg 87 (119)
...||+. -+-+|||.||-||+..|.- -+|. -+.|.-+|+|.--
T Consensus 139 CKpCpva--q~a~vCGsDghtYss~ckLe~~aC~~sksiav~c~g~cpcp 186 (434)
T KOG3555|consen 139 CKPCPVA--QPAFVCGSDGHTYSSRCKLEYHACHVSKSIAVICEGPCPCP 186 (434)
T ss_pred CccCCcc--cccceecCCCCeehhhhhHHHHhhhhhhhhhhhhCCCCCCC
Confidence 3459985 5789999999999998832 3443 3456778888743
No 12
>COG5058 LAG1 Protein transporter of the TRAM (translocating chain-associating membrane) superfamily, longevity assurance factor [Intracellular trafficking and secretion]
Probab=81.48 E-value=1.1 Score=39.56 Aligned_cols=15 Identities=67% Similarity=1.034 Sum_probs=13.0
Q ss_pred hhHHHHHHHHHHHHH
Q 033423 96 GQALLLVHIVWLFLL 110 (119)
Q Consensus 96 ~qalllvHivwl~~l 110 (119)
-||||||||+|++++
T Consensus 345 l~aLQlvniyWl~lI 359 (395)
T COG5058 345 LQALQLVNIYWLFLI 359 (395)
T ss_pred HHHHHHHHHHHHHHH
Confidence 489999999999864
No 13
>PF12178 INCENP_N: Chromosome passenger complex (CPC) protein INCENP N terminal; InterPro: IPR022006 This domain family is found in eukaryotes, and is approximately 40 amino acids in length. INCENP is a regulatory protein in the chromosome passenger complex. It is involved in regulation of the catalytic protein Aurora B. It performs this function in association with two other proteins - Survivin and Borealin. These proteins form a tight three-helical bundle. The N-terminal domain is the domain involved in formation of this three helical bundle. ; PDB: 2QFA_C.
Probab=40.21 E-value=12 Score=23.39 Aligned_cols=8 Identities=38% Similarity=0.663 Sum_probs=6.2
Q ss_pred HHHHHHHH
Q 033423 101 LVHIVWLF 108 (119)
Q Consensus 101 lvHivwl~ 108 (119)
-+|+|||=
T Consensus 24 ~~d~vWLe 31 (38)
T PF12178_consen 24 NKDMVWLE 31 (38)
T ss_dssp HTHHHHHH
T ss_pred chhhHHHH
Confidence 37999983
No 14
>COG3350 Uncharacterized conserved protein [Function unknown]
Probab=37.09 E-value=18 Score=24.14 Aligned_cols=7 Identities=71% Similarity=1.559 Sum_probs=5.6
Q ss_pred CCccccC
Q 033423 53 PDPVCGV 59 (119)
Q Consensus 53 ~dpVCGt 59 (119)
-|||||.
T Consensus 4 iDPVcgm 10 (53)
T COG3350 4 IDPVCGM 10 (53)
T ss_pred ccCCcCc
Confidence 5888886
No 15
>PRK14762 membrane protein; Provisional
Probab=33.90 E-value=42 Score=19.78 Aligned_cols=15 Identities=40% Similarity=0.851 Sum_probs=11.0
Q ss_pred HHHHHHHHHHHhhcC
Q 033423 105 VWLFLLALSLLLGVF 119 (119)
Q Consensus 105 vwl~~lg~~~~~g~f 119 (119)
.-.|+.|+.+++|.|
T Consensus 9 ~iifligllvvtgvf 23 (27)
T PRK14762 9 LIIFLIGLLVVTGVF 23 (27)
T ss_pred HHHHHHHHHHHHHHH
Confidence 335677889999875
No 16
>PHA02325 hypothetical protein
Probab=29.66 E-value=27 Score=24.59 Aligned_cols=14 Identities=57% Similarity=1.469 Sum_probs=11.7
Q ss_pred ccccC---CCceeccCC
Q 033423 55 PVCGV---DGVTYWCGC 68 (119)
Q Consensus 55 pVCGt---DGvTY~~gC 68 (119)
|+||+ ||--||+|=
T Consensus 7 PkC~A~WldgqhYWsgT 23 (72)
T PHA02325 7 PKCGARWLDGQHYWSGT 23 (72)
T ss_pred CccCCEeEcceeeeccC
Confidence 55998 999999954
No 17
>PF11027 DUF2615: Protein of unknown function (DUF2615); InterPro: IPR020309 This entry represents a group of uncharacterised protein from the Metazoa, including CD034 (or C4orf34) and YQF4 (or C34C12.4).
Probab=28.47 E-value=88 Score=22.99 Aligned_cols=24 Identities=21% Similarity=0.519 Sum_probs=18.3
Q ss_pred ccchhHHHHHHHHHHHHHHHHHHh
Q 033423 93 PLPGQALLLVHIVWLFLLALSLLL 116 (119)
Q Consensus 93 ~~~~qalllvHivwl~~lg~~~~~ 116 (119)
...+....++=++|++++-+..++
T Consensus 49 ~~~~~~~~~~~~~w~~~A~~ly~~ 72 (103)
T PF11027_consen 49 GDGGNSMFMMMMLWMVLAMALYLL 72 (103)
T ss_pred CCCCccHHHHHHHHHHHHHHHHHc
Confidence 344577888889999998777665
No 18
>KOG4075 consensus Cytochrome c oxidase, subunit IV/COX5b [Energy production and conversion]
Probab=25.14 E-value=48 Score=26.51 Aligned_cols=18 Identities=33% Similarity=0.371 Sum_probs=15.1
Q ss_pred HHHHHHHHHHHHHHhhcC
Q 033423 102 VHIVWLFLLALSLLLGVF 119 (119)
Q Consensus 102 vHivwl~~lg~~~~~g~f 119 (119)
+-++|++++||.+.+++|
T Consensus 102 v~g~~~~f~Gl~~~v~l~ 119 (167)
T KOG4075|consen 102 VFGVAGFFLGLTISVILF 119 (167)
T ss_pred hhhHHHHHHHHHHHHHHH
Confidence 457899999999988875
No 19
>KOG1607 consensus Protein transporter of the TRAM (translocating chain-associating membrane) superfamily [Intracellular trafficking, secretion, and vesicular transport]
Probab=23.42 E-value=65 Score=27.81 Aligned_cols=14 Identities=50% Similarity=1.094 Sum_probs=10.4
Q ss_pred hHHHHHHHHHHHHH
Q 033423 97 QALLLVHIVWLFLL 110 (119)
Q Consensus 97 qalllvHivwl~~l 110 (119)
++|+++||.|...+
T Consensus 268 ~~Lqll~i~W~~lI 281 (318)
T KOG1607|consen 268 LALQLLHIYWFYLI 281 (318)
T ss_pred HHHHHHHHHHHHHH
Confidence 67888888887653
Done!